Paolo Ghia, MD, PhD, is a Professor at the Università Vita-Salute San Raffaele, Milan, Italy, and director of the Strategic Research Program on CLL.
Dr Ghia received his medical degree from the University of Torino, Torino, Italy, and subsequently completed a residency in internal medicine. He then received a PhD at the Basel Institute for Immunology, Basel, Switzerland. Afterwards, Dr Ghia continued his studies at the Dana-Farber Cancer Institute at Harvard Medical School, Boston, MA.